ID29596A - Zat terapeutik untuk ngf - Google Patents
Zat terapeutik untuk ngfInfo
- Publication number
- ID29596A ID29596A IDW20002309A ID20002309A ID29596A ID 29596 A ID29596 A ID 29596A ID W20002309 A IDW20002309 A ID W20002309A ID 20002309 A ID20002309 A ID 20002309A ID 29596 A ID29596 A ID 29596A
- Authority
- ID
- Indonesia
- Prior art keywords
- ngf
- therapeutic substance
- trk
- domain
- therapeutic agent
- Prior art date
Links
- 239000000126 substance Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009510 drug design Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00686—Automatic
- B01J2219/00689—Automatic using computers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/007—Simulation or vitual synthesis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9807781.1A GB9807781D0 (en) | 1998-04-09 | 1998-04-09 | Therapeutic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29596A true ID29596A (id) | 2001-09-06 |
Family
ID=10830230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002309A ID29596A (id) | 1998-04-09 | 1999-04-09 | Zat terapeutik untuk ngf |
Country Status (12)
Country | Link |
---|---|
US (2) | US20030097667A1 (id) |
EP (2) | EP1661994A1 (id) |
JP (1) | JP2002511262A (id) |
KR (1) | KR100624881B1 (id) |
AT (1) | ATE320490T1 (id) |
AU (1) | AU769317B2 (id) |
CA (1) | CA2325332A1 (id) |
DE (1) | DE69930378T2 (id) |
GB (1) | GB9807781D0 (id) |
ID (1) | ID29596A (id) |
WO (1) | WO1999053055A2 (id) |
ZA (1) | ZA200005821B (id) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030096753A1 (en) * | 1998-04-09 | 2003-05-22 | Robertson Alan George Simpson | Therapeutic agent |
GB9807781D0 (en) * | 1998-04-09 | 1998-06-10 | Univ Bristol | Therapeutic agent |
GB0020504D0 (en) * | 2000-08-18 | 2000-10-11 | Univ Bristol | Therapeutic method |
GB0122400D0 (en) * | 2001-09-17 | 2001-11-07 | Univ Bristol | Polypeptide purification method |
US6919426B2 (en) * | 2002-09-19 | 2005-07-19 | Amgen Inc. | Peptides and related molecules that modulate nerve growth factor activity |
CN102746399B (zh) | 2002-12-24 | 2016-03-02 | 里纳特神经系统学公司 | 抗ngf抗体及其使用方法 |
US9498530B2 (en) | 2002-12-24 | 2016-11-22 | Rinat Neuroscience Corp. | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
GB0303362D0 (en) * | 2003-02-13 | 2003-03-19 | Enact Pharma Plc | Tissue regeneration |
EP1857146A1 (en) * | 2006-05-16 | 2007-11-21 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Treatment of respiratory disorders |
DE102006052504A1 (de) | 2006-11-06 | 2008-05-08 | Temper, Rupert | Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit |
ES2910305T3 (es) | 2010-08-19 | 2022-05-12 | Zoetis Belgium S A | Anticuerpos anti-NGF y su uso |
US9783602B2 (en) | 2010-12-01 | 2017-10-10 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
JP6108261B2 (ja) * | 2011-01-13 | 2017-04-05 | 国立大学法人 千葉大学 | 疼痛の予防および/または治療剤のスクリーニング方法並びにこれに用いるためのキット |
EP2859018B1 (en) | 2012-06-06 | 2021-09-22 | Zoetis Services LLC | Caninized anti-ngf antibodies and methods thereof |
IT201600086689A1 (it) * | 2016-08-23 | 2018-02-23 | Neuheart S R L | PEPTIDI AVENTI ATTIVITÀ AGONISTA NEI CONFRONTI DEL RECETTORE TrkA E/O PEPTIDI AVENTI ATTIVITÀ ANTAGONISTA DI NGF |
KR20200130696A (ko) | 2018-03-12 | 2020-11-19 | 조에티스 서비시즈 엘엘씨 | 항-ngf 항체 및 이의 방법 |
AU2020240120A1 (en) * | 2019-03-20 | 2021-09-30 | Elanco Us Inc. | NGF antagonists for medical use |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK166763C (da) * | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
IL101661A (en) * | 1991-04-23 | 1998-02-08 | Regeneron Pharma | Method for detecting, identifying or measuring agents having neurotrophin activity |
US5877016A (en) * | 1994-03-18 | 1999-03-02 | Genentech, Inc. | Human trk receptors and neurotrophic factor inhibitors |
US5844092A (en) * | 1994-03-18 | 1998-12-01 | Genentech, Inc. | Human TRK receptors and neurotrophic factor inhibitors |
GB9525180D0 (en) * | 1995-12-08 | 1996-02-07 | Univ Mcgill | Design of hormone-like antibodies with agonistic and antagonistic fuctions |
GB9616105D0 (en) * | 1996-07-31 | 1996-09-11 | Univ Kingston | TrkA binding site of NGF |
CA2271950A1 (en) * | 1996-11-22 | 1998-05-28 | Sugen, Inc. | Receptor tyrosine kinase genes |
FR2776661B1 (fr) * | 1998-03-26 | 2002-04-05 | Centre Nat Rech Scient | Polypeptide immunoreactif du recepteur trka du ngf et utilisations |
US20030096753A1 (en) * | 1998-04-09 | 2003-05-22 | Robertson Alan George Simpson | Therapeutic agent |
GB9807781D0 (en) * | 1998-04-09 | 1998-06-10 | Univ Bristol | Therapeutic agent |
GB0020504D0 (en) * | 2000-08-18 | 2000-10-11 | Univ Bristol | Therapeutic method |
GB0122400D0 (en) * | 2001-09-17 | 2001-11-07 | Univ Bristol | Polypeptide purification method |
-
1998
- 1998-04-09 GB GBGB9807781.1A patent/GB9807781D0/en not_active Ceased
-
1999
- 1999-04-09 WO PCT/GB1999/001108 patent/WO1999053055A2/en active IP Right Grant
- 1999-04-09 EP EP05023460A patent/EP1661994A1/en not_active Withdrawn
- 1999-04-09 KR KR1020007011230A patent/KR100624881B1/ko not_active IP Right Cessation
- 1999-04-09 JP JP2000543603A patent/JP2002511262A/ja not_active Withdrawn
- 1999-04-09 EP EP99915913A patent/EP1068315B1/en not_active Expired - Lifetime
- 1999-04-09 DE DE69930378T patent/DE69930378T2/de not_active Expired - Fee Related
- 1999-04-09 AU AU34336/99A patent/AU769317B2/en not_active Ceased
- 1999-04-09 AT AT99915913T patent/ATE320490T1/de not_active IP Right Cessation
- 1999-04-09 ID IDW20002309A patent/ID29596A/id unknown
- 1999-04-09 CA CA002325332A patent/CA2325332A1/en not_active Abandoned
-
2000
- 2000-10-19 ZA ZA200005821A patent/ZA200005821B/xx unknown
-
2002
- 2002-10-01 US US10/260,352 patent/US20030097667A1/en not_active Abandoned
-
2006
- 2006-09-13 US US11/519,772 patent/US20070067856A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200005821B (en) | 2001-12-03 |
EP1661994A1 (en) | 2006-05-31 |
CA2325332A1 (en) | 1999-10-21 |
KR20010042565A (ko) | 2001-05-25 |
WO1999053055A3 (en) | 2000-03-30 |
DE69930378D1 (de) | 2006-05-11 |
ATE320490T1 (de) | 2006-04-15 |
WO1999053055A2 (en) | 1999-10-21 |
AU3433699A (en) | 1999-11-01 |
EP1068315B1 (en) | 2006-03-15 |
GB9807781D0 (en) | 1998-06-10 |
KR100624881B1 (ko) | 2006-09-15 |
US20070067856A1 (en) | 2007-03-22 |
US20030097667A1 (en) | 2003-05-22 |
DE69930378T2 (de) | 2007-01-11 |
JP2002511262A (ja) | 2002-04-16 |
EP1068315A2 (en) | 2001-01-17 |
AU769317B2 (en) | 2004-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID29596A (id) | Zat terapeutik untuk ngf | |
DE50011194D1 (de) | Medizinisches Instrument zum Präparieren von Gewebe | |
ATE295361T1 (de) | Dimerverbindungen und als inhibitoren der neuramidinase | |
DE69832497D1 (de) | Chirurgische instrumente mit verbesserter zugfähigkeit | |
DE69522301D1 (de) | Dichtungsanordnung zur Einführung von chirurgischen Instrumenten | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
DE69738755D1 (de) | Sofort auflösbare medizinische zusammenstellung | |
DE60121988D1 (de) | Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln | |
DE69826683D1 (de) | Therapeutische zusammensetzungen, enthaltend amlopidin und atorvastatin | |
DE60002696D1 (de) | Redundanzbeseitigung in der persistenz von objektgraphen | |
EE9900345A (et) | Sulfonüülkarbamiidi ja glitasooni sünergistilised kombinatsioonid diabeedi raviks | |
DE59910745D1 (de) | Bipolares medizinisches instrument | |
DE69932273D1 (de) | Befestigung von Biomolekülen an Oberflächen von medizinischen Geräten | |
DE60020019D1 (de) | Prüfung der Dekodierung von Bitströmen | |
PT1161420E (pt) | Fungicidas de pirazol-carboxanilidas | |
DE69827132T8 (de) | Anordnung zur anwendung von fibrin-kleber | |
DE69019363D1 (de) | Desinfizierende zusammensetzung und desinfektionsverfahren. | |
EE200100243A (et) | 5HT1 retseptori agonistid ja metoklopramiid migreeni raviks | |
DE50010774D1 (de) | Anlage zur bearbeitung von wafern | |
DE50013866D1 (de) | Anlage zur bearbeitung von wafern | |
DE59900969D1 (de) | Neue Diaminobenzol-Derivate und diese Verbindungen enthaltende Färbemittel | |
PT944308E (pt) | Misturas sinergeticas de agentes fitosanitarios | |
DK1057813T3 (da) | Indolderivater og medicinske sammensætninger indeholdende de samme | |
BR9406435A (pt) | Utilização de derivados de indol como antagonistas de 5HT1 | |
IS5951A (is) | 5HT1 mótlyf fyrir meðferð gegn þunglyndi |